Liposomal paclitaxel

DRUG6 trials

Conditions

CancerEsophageal CancerEsophageal CarcinomaHead and Neck Squamous Cell CarcinomaLocally AdvancedNeoadjuvant TherapyNon-small Cell Lung CancerPembrolizumab

Phase 1

Clinical Study of Liposomal Paclitaxel in Chinese Patients

NCT00881101

Nanjing Sike Pharmaceutical Co., Ltd.Solid Tumor

Start: 2009-04-30End: 2009-12-31Target: 15Updated: 2009-04-15

Phase 2

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

CompletedNCT00016900

Memorial Sloan Kettering Cancer CenterEsophageal Cancer

Start: 2000-12-31End: 2001-06-30Updated: 2013-06-18

Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma

CompletedNCT02861690

Sun Yat-sen UniversityEsophageal Carcinoma

Start: 2010-01-31End: 2016-01-31Updated: 2016-08-10

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

RecruitingNCT05766800

Shanghai Pulmonary Hospital, Shanghai, ChinaLocally Advanced, Non-small Cell Lung Cancer

Start: 2023-03-14End: 2027-04-01Target: 100Updated: 2024-09-19

Phase 3

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

RecruitingNCT06102395

Beijing Tongren HospitalHead and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab

Start: 2023-05-01End: 2030-04-30Target: 272Updated: 2023-10-30

Phase 4

Pharmacokinetics Study of Liposomal Paclitaxel in Humans

CompletedNCT00606515

Shandong Luye Pharmaceutical Co., Ltd.Cancer

Start: 2008-02-29End: 2008-10-31Target: 16Updated: 2009-02-10

Related Papers

Induction therapy with PD-1 antibody combined with platinum-based doublet chemotherapy for locally-advanced non-small cell lung cancer: A randomised controlled, open-label, phase 2 trial.

Journal of Clinical Oncology2024-06-012 citations

EFFECT-neo: A phase 3 study of pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy in patients with resectable locally advanced head and neck squamous cell carcinoma.

Journal of Clinical Oncology2024-06-011 citations